Skip to content

Clinical trials

Completed Glycogen Storage Disease Type II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Status: Completed Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20042
20053
20074
20082
20091
20102
20113
20123
20135
20142
20155
20163
20174
20182
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company19
Duke University8
University of Florida6
Amicus Therapeutics5
University of California, Irvine2
AskBio Inc1
BioMarin Pharmaceutical1
Dwight Koeberl, M.D., Ph.D.1
MidAtlantic Retina1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II49
Macular Degeneration3
Glycogen Storage Disease2
Lysosomal Storage Diseases2
Muscular Diseases2
Anaphylaxis1
Dermatomyositis1
Fibrosis1
Glycogen Storage Disease Type VII1
Heartburn1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.